Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Long-term outcomes of immunosuppressed renal transplant recipients with malignancies
Autore:
Gunji, Y; Sakamoto, K; Kamura, K; Yamada, K; Kashiwabara, H; Shimada, H; Hori, S; Suzuki, T; Ochiai, T;
Indirizzi:
Chiba Univ, Sch Med, Dept Surg 2, Chuo Ku, Chiba 2608670, Japan Chiba Univ Chiba Japan 2608670 ept Surg 2, Chuo Ku, Chiba 2608670, Japan Sakura Natl Hosp, Dept Clin Res, Chiba 2850825, Japan Sakura Natl Hosp Chiba Japan 2850825 Dept Clin Res, Chiba 2850825, Japan Sakura Natl Hosp, Dept Urol, Chiba 2850825, Japan Sakura Natl Hosp ChibaJapan 2850825 sp, Dept Urol, Chiba 2850825, Japan Sakura Natl Hosp, Dept Transplant Surg, Chiba 2850825, Japan Sakura Natl Hosp Chiba Japan 2850825 ansplant Surg, Chiba 2850825, Japan
Titolo Testata:
SURGERY TODAY
fascicolo: 6, volume: 31, anno: 2001,
pagine: 492 - 496
SICI:
0941-1291(2001)31:6<492:LOOIRT>2.0.ZU;2-T
Fonte:
ISI
Lingua:
ENG
Soggetto:
CANCER RISK; CYCLOSPORINE; KIDNEY; ALLOGRAFT; DIALYSIS; DISEASE; THERAPY; TUMORS;
Keywords:
renal transplantation; malignant disease; immunosuppressant;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
23
Recensione:
Indirizzi per estratti:
Indirizzo: Gunji, Y Chiba Univ, Sch Med, Dept Surg 2, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan Chiba Univ 1-8-1 Inohana Chiba Japan 2608670 hiba 2608670, Japan
Citazione:
Y. Gunji et al., "Long-term outcomes of immunosuppressed renal transplant recipients with malignancies", SURG TODAY, 31(6), 2001, pp. 492-496

Abstract

This study analyzes ten cases of malignancy in a cohort of 183 renal transplant recipients, examining surgical management, postoperative immunosuppressive therapy, and long-term outcome. One of these ten patients, who had malignant lymphoma of the jejunum, died of the neoplasm, but the other nine patients did not show any signs of tumor recurrence after removal. All of these nine patients, except for one who had transplant renal cell carcinoma (RCC), received the same dose of immunosuppressive agents after surgery for the malignant disease. Seven patients were still alive at the time of this report, six of whom had good transplant renal function. The findings of this study indicate that even if immunosuppressive agents predispose to the development of cancer, it is not necessary to reduce their dose after removalof the tumor.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/09/20 alle ore 15:22:15